Vail DM - Search Results

1

Use of 3'-deoxy-3'-[18F]fluorothymidine PET/CT for evaluating response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma.

Lawrence J, Vanderhoek M, Barbee D, Jeraj R, Tumas DB, Vail DM. Lawrence J, et al. Among authors: vail dm. Vet Radiol Ultrasound. 2009 Nov-Dec;50(6):660-8. doi: 10.1111/j.1740-8261.2009.01612.x. Vet Radiol Ultrasound. 2009. PMID: 19999354

2

Efficacy of mitoxantrone against various neoplasms in dogs.

Ogilvie GK, Obradovich JE, Elmslie RE, Vail DM, Moore AS, Straw RC, Dickinson K, Cooper MF, Withrow SJ. Ogilvie GK, et al. Among authors: vail dm. J Am Vet Med Assoc. 1991 May 1;198(9):1618-21. J Am Vet Med Assoc. 1991. PMID: 2061177

3

Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs.

Ogilvie GK, Vail DM, Klein MK, Powers BE, Dickinson K. Ogilvie GK, et al. Among authors: vail dm. J Am Vet Med Assoc. 1991 May 15;198(10):1762-4. J Am Vet Med Assoc. 1991. PMID: 2071476

4

Evaluation of prognostic factors for dogs with synovial sarcoma: 36 cases (1986-1991).

Vail DM, Powers BE, Getzy DM, Morrison WB, McEntee MC, O'Keefe DA, Norris AM, Withrow SJ. Vail DM, et al. J Am Vet Med Assoc. 1994 Nov 1;205(9):1300-7. J Am Vet Med Assoc. 1994. PMID: 7698942

5

Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.

Vail DM, Kisseberth WC, Obradovich JE, Moore FM, London CA, MacEwen EG, Ritter MA. Vail DM, et al. Exp Hematol. 1996 Jun;24(7):807-15. Exp Hematol. 1996. PMID: 8647231

6

Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model.

Vail DM, Chun R, Thamm DH, Garrett LD, Cooley AJ, Obradovich JE. Vail DM, et al. Clin Cancer Res. 1998 Jun;4(6):1567-71. Clin Cancer Res. 1998. PMID: 9626479 Clinical Trial.

7

An accelerated technique for irradiation of malignant canine nasal and paranasal sinus tumors.

Adams WM, Miller PE, Vail DM, Forrest LJ, MacEwen EG. Adams WM, et al. Among authors: vail dm. Vet Radiol Ultrasound. 1998 Sep-Oct;39(5):475-81. doi: 10.1111/j.1740-8261.1998.tb01637.x. Vet Radiol Ultrasound. 1998. PMID: 9771602 Review.

8

Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.

Kurzman ID, MacEwen EG, Rosenthal RC, Fox LE, Keller ET, Helfand SC, Vail DM, Dubielzig RR, Madewell BR, Rodriguez CO Jr, et al. Kurzman ID, et al. Among authors: vail dm. Clin Cancer Res. 1995 Dec;1(12):1595-601. Clin Cancer Res. 1995. PMID: 9815961 Clinical Trial.

9

Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.

Hershey AE, Kurzman ID, Forrest LJ, Bohling CA, Stonerook M, Placke ME, Imondi AR, Vail DM. Hershey AE, et al. Among authors: vail dm. Clin Cancer Res. 1999 Sep;5(9):2653-9. Clin Cancer Res. 1999. PMID: 10499645

10

Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.

MacEwen EG, Kurzman ID, Vail DM, Dubielzig RR, Everlith K, Madewell BR, Rodriguez CO Jr, Phillips B, Zwahlen CH, Obradovich J, Rosenthal RC, Fox LE, Rosenberg M, Henry C, Fidel J. MacEwen EG, et al. Among authors: vail dm. Clin Cancer Res. 1999 Dec;5(12):4249-58. Clin Cancer Res. 1999. PMID: 10632367 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters